-The Economic Times If India is now debating opening the books and operations of political parties to the public, it's because of these six people who pulled strategic levers and applied relentless pressure. Soma Banerjee traces a four-year effort that converted intent to action Balwant Singh Khera, a politician from Hoshiarpur in Punjab, is not a name that will strike a chord in mainstream politics or social discourse today. It might in...

-Down to Earth A Sehore farmer finds a unique pigeon pea variety that bears pods three to four times in a row When their two soybean crops failed in two consecutive years, farmer Raj Kumar Rathore tried to convince his parents to experiment with other crops. But it only angered them. They were not ready to give up farming the traditional crop of Madhya Pradesh's Sehore district. He was ousted from the...

-The Hindu Seven years after the first warning in June 2006 from the U.S. Food and Drug Administration (FDA) and five years after the Department of Justice initiated legal proceedings against the company, Ranbaxy is back in the news for the same wrong reasons. Last fortnight it pleaded guilty to felony charges in the U.S., admitting to selling adulterated drugs with intent to defraud, not reporting that its drugs failed...

-The Telegraph Illegal hunting in Arunachal Pradesh primarily for meat on the table or for money from the market may be threatening several protected or rare wildlife species, a survey in the state's Ziro Valley has indicated. Researchers from the Wildlife Institute of India, (WII) Dehradun, have documented hunting of leopards, marbled cats, black bears, orange-bellied squirrels, among other species, mainly for meat, skin, and commercial sales in six villages of Ziro...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...